Nek2 was reported as a prognostic biomarker for lung cancer (Shi et al., 2017), and knockdown of Nek2 gene with siRNA in xenograft mice decreased tumor size and increased survival for liver metastasized pancreatic cancer (Kokuryo et al., 2016). The gene discussed is NEK2; the disease is familial pancreatic carcinoma.